BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30511098)

  • 1. A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.
    Sanjo N; Nose Y; Shishido-Hara Y; Mizutani S; Sekijima Y; Aizawa H; Tanizawa T; Yokota T
    J Neurol; 2019 Feb; 266(2):369-377. PubMed ID: 30511098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.
    Aly L; Yousef S; Schippling S; Jelcic I; Breiden P; Matschke J; Schulz R; Bofill-Mas S; Jones L; Demina V; Linnebank M; Ogg G; Girones R; Weber T; Sospedra M; Martin R
    Brain; 2011 Sep; 134(Pt 9):2687-702. PubMed ID: 21908874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.
    Lima MA; Marzocchetti A; Autissier P; Tompkins T; Chen Y; Gordon J; Clifford DB; Gandhi RT; Venna N; Berger JR; Koralnik IJ
    J Virol; 2007 Apr; 81(7):3361-8. PubMed ID: 17229701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
    Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
    N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome.
    Gheuens S; Bord E; Kesari S; Simpson DM; Gandhi RT; Clifford DB; Berger JR; Ngo L; Koralnik IJ
    J Virol; 2011 Jul; 85(14):7256-63. PubMed ID: 21543472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology for severe inflammatory PML with PD1/PD-L1 expression of favorable prognosis: What's a prognostic factor for PML-IRIS?
    Shishido-Hara Y; Akimoto J; Fukami S; Kohno M; Matsubayashi J; Nagao T
    Neuropathology; 2024 Feb; 44(1):47-58. PubMed ID: 37424276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
    Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.
    Vendrely A; Bienvenu B; Gasnault J; Thiebault JB; Salmon D; Gray F
    Acta Neuropathol; 2005 Apr; 109(4):449-55. PubMed ID: 15739098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells.
    Wüthrich C; Kesari S; Kim WK; Williams K; Gelman R; Elmeric D; De Girolami U; Joseph JT; Hedley-Whyte T; Koralnik IJ
    J Neurovirol; 2006 Apr; 12(2):116-28. PubMed ID: 16798673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection.
    Martin-Blondel G; Bauer J; Cuvinciuc V; Uro-Coste E; Debard A; Massip P; Delisle MB; Lassmann H; Marchou B; Mars LT; Liblau RS
    Neurology; 2013 Sep; 81(11):964-70. PubMed ID: 23935178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.
    Jelcic I; Jelcic I; Kempf C; Largey F; Planas R; Schippling S; Budka H; Sospedra M; Martin R
    Ann Neurol; 2016 Mar; 79(3):404-18. PubMed ID: 26874214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy.
    Tan CS; Bord E; Broge TA; Glotzbecker B; Mills H; Gheuens S; Rosenblatt J; Avigan D; Koralnik IJ
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):244-8. PubMed ID: 22549384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
    Koralnik IJ; Du Pasquier RA; Letvin NL
    J Virol; 2001 Apr; 75(7):3483-7. PubMed ID: 11238876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].
    Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J
    Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Schmitz JE; Zheng Y; Martin K; Peyerl FW; Lifton M; Gorgone D; Autissier P; Letvin NL; Koralnik IJ
    J Virol; 2003 Nov; 77(22):11918-26. PubMed ID: 14581528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
    Bauer J; Gold R; Adams O; Lassmann H
    Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
    Holmes A; Wellings T; Walsh O; Rowlings P
    J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control.
    Schwab N; Ulzheimer JC; Fox RJ; Schneider-Hohendorf T; Kieseier BC; Monoranu CM; Staugaitis SM; Welch W; Jilek S; Du Pasquier RA; Brück W; Toyka KV; Ransohoff RM; Wiendl H
    Neurology; 2012 Feb; 78(7):458-67; discussion 465. PubMed ID: 22302546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial?
    Du Pasquier RA; Koralnik IJ
    J Neurovirol; 2003; 9 Suppl 1():25-31. PubMed ID: 12709868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two patients with progressive multifocal leukoencephalopathy with immune response against JC virus showing good long-term outcome by combination therapy of mefloquine, mirtazapine, and risperidone].
    Akagawa Y; Ueno A; Ikeda J; Ishii W; Shishido-Hara Y; Sekijima Y
    Rinsho Shinkeigaku; 2018 May; 58(5):324-331. PubMed ID: 29710027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.